News & Blog

The Interstitial Cystitis Association (ICA) advocates for interstitial cystitis (IC) research dedicated to discovery of a cure and better treatments, raises awareness, and serves as a central hub for the healthcare providers, researchers and millions of patients who suffer with constant urinary urgency and frequency and extreme bladder pain called IC. Below please find a notice for a research study being conducted by Allergan that we thought may be of interest to you.

ICA is providing this information as a service and is neither sponsoring nor conducting this research study. ICA does not have any participation in determining the acceptance criteria or in selecting study participants. ICA’s sole intent is to make potentially eligible participants aware of this study being conducted by Allergan. Should you have any questions regarding the study, please contact the study coordinator directly.

Do you or someone you know suffer from IC/BPS? If so, you are familiar with the pain that can make it difficult to enjoy life. Allergan, Inc. is enrolling participants for a research study investigating a drug device to investigate the safety and effectiveness of a continuous release of lidocaine inserted into the bladder compared with placebo for the symptoms of IC/BPS in female patients. All patients will have the opportunity to receive the active study drug if they request and satisfy the criteria.

Click here to learn more.